Search Results:  EUR — European & Eurasian Affairs  (5)

  • Statement from the first ACT-Accelerator Facilitation Council meeting

    We acknowledge the urgency of catalysing a step-change in political support and financing for the ACT- Accelerator in order to enable it to deliver on its mission of accelerating the discovery and deployment of new COVID-19 tools to all people, everywhere.

    Roles: Everyone: All Users

    Regions: Norway , South Africa

    Topics: Coronavirus (COVID-19), Global Health

  • Coronavirus Global Response: Access to COVID-19 Tools-Accelerator Facilitation Council holds inaugural meeting

    Today Dr Tedros Adhanom Ghebreyesus, WHO Director-General, and Dr Ursula von der Leyen, President of the European Commission, co-hosted the inaugural meeting of the Access to COVID-19 Tools (ACT) Accelerator Facilitation Council.

    Roles: Everyone: All Users

    Regions: Canada , China, France , Italy , Norway , Rwanda , South Africa , United Kingdom , Uzbekistan

    Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health

  • 172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility

    • Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world
    • 80 potentially self-financing countries have submitted non-binding expressions of interest to the Gavi-coor

      Roles: Everyone: All Users

      Regions: Afghanistan, Argentina, Canada , Chile, China, France , Ireland , Norway , Tonga , United Kingdom , United States , West Bank , Zambia

      Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Energy, Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

    • European Medicines Agency (EMA) approval of the dapivirine ring for HIV prevention for women in high HIV burden settings

      The European Medicines Agency announced today that its human medicines committee provided a positive benefit-risk opinion on the use of the Dapivirine Vaginal Ring (DPV-VR) for HIV prevention. WHO stresses that when providing HIV prevention for women it is always critical to provide these alongside other services including STI diagnosis and treatment, HIV testing and links to antiretroviral therapy for all women who test positive and a range of contraception options.

      Roles: Everyone: All Users

      Regions: Kenya

      Topics: Global Health, Global Women's Issues

    • Addressing the crisis in antibiotic development

      Today, more than 20 leading biopharmaceutical companies are announcing the launch of the AMR Action Fund that will invest in developing innovative antibacterial treatments. The Fund aims to bring 2-4 new treatments to patients by 2030. This initiative is a significant step towards addressing the current crisis in antibacterial treatment development.

  • Regions









































































































































































































































  • Topics